Ziprasidone for severe conduct and other disruptive behavior disorders in children and adolescents - a placebo controlled, randomized, double blind clinical trial
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Ziprasidone (Primary)
- Indications Behavioural disorders
- Focus Therapeutic Use
- 17 Nov 2008 Investigator names updated.
- 10 Nov 2008 Planned number of patients changed from 50 to 51.
- 10 Nov 2008 Status changed from recruiting to completed.